Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis

NCT05702268 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Atopic Dermatitis

Interventions

DRUG: ICP-332
DRUG: ICP-332 Placebo

Sponsor

Beijing InnoCare Pharma Tech Co., Ltd.